Further, LPA reportedly induces endothelial cell barrier dysfunction and vascular leak [44], which could be the reason why the LPAR1 antagonist is so effective in preventing lung metastasis of osteosarcoma and slightly reducing the initial amount of cancer cells trapped in the lung. This evidence concerns the gene LPAR1 and osteosarcoma.